Literature DB >> 12394170

Reconstitution of thymic function after stem cell transplantation in humans.

Frances T Hakim1, Ronald E Gress.   

Abstract

The reconstitution of T-cell populations is a critical component of immune recovery after allogeneic stem cell transplantation. Recent studies have used new techniques to focus on the interplay of thymopoiesis and peripheral expansion that defines T-cell repopulation. Peripheral expansion, driven by host cytokines and antigenic stimulation, dominates early recovery. However, this expansion is often transient and is characterized by limited repertoire diversity. Renewed thymopoiesis has been found to play a critical role in the recovery of repertoire diversity and stable repopulation. The insights gained into the regulation of these processes may provide new therapies to enhance recovery.

Entities:  

Mesh:

Year:  2002        PMID: 12394170     DOI: 10.1097/00062752-200211000-00004

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  12 in total

Review 1.  Oral graft-versus-host disease.

Authors:  M M Imanguli; I Alevizos; R Brown; S Z Pavletic; J C Atkinson
Journal:  Oral Dis       Date:  2008-07       Impact factor: 3.511

2.  Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.

Authors:  Sarfraz A Memon; Claude Sportès; Francis A Flomerfelt; Ronald E Gress; Frances T Hakim
Journal:  J Immunol Methods       Date:  2011-10-01       Impact factor: 2.303

3.  Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells.

Authors:  Simona W Rossi; Lukas T Jeker; Tomoo Ueno; Sachiyo Kuse; Marcel P Keller; Saulius Zuklys; Andrei V Gudkov; Yousuke Takahama; Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

4.  Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation.

Authors:  Mathias M Hauri-Hohl; Marcel P Keller; Jason Gill; Katrin Hafen; Esther Pachlatko; Thomas Boulay; Annick Peter; Georg A Holländer; Werner Krenger
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

5.  Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Evert-Jan Wils; Bronno van der Holt; Annoek E C Broers; Sandra J Posthumus-van Sluijs; Jan-Willem Gratama; Eric Braakman; Jan J Cornelissen
Journal:  Haematologica       Date:  2011-08-22       Impact factor: 9.941

Review 6.  Harnessing the biology of IL-7 for therapeutic application.

Authors:  Crystal L Mackall; Terry J Fry; Ronald E Gress
Journal:  Nat Rev Immunol       Date:  2011-05       Impact factor: 53.106

7.  Clinical and experimental study on therapeutic effect of umbilical cord blood transplantation on severe viral hepatitis.

Authors:  Xiao-Peng Tang; Xu Yang; Hui Tan; Yi-Ling Ding; Min Zhang; Wen-Long Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.

Authors:  Stephan Mielke; Katayoun Rezvani; Bipin N Savani; Raquel Nunes; Agnes S M Yong; John Schindler; Roger Kurlander; Victor Ghetie; Elizabeth J Read; Scott R Solomon; Ellen S Vitetta; A John Barrett
Journal:  Blood       Date:  2007-05-03       Impact factor: 22.113

Review 9.  Reconstitution of the immune system after hematopoietic stem cell transplantation in humans.

Authors:  Jan Storek; Michelle Geddes; Faisal Khan; Bertrand Huard; Claudine Helg; Yves Chalandon; Jakob Passweg; Eddy Roosnek
Journal:  Semin Immunopathol       Date:  2008-10-24       Impact factor: 9.623

Review 10.  The immunopathology of thymic GVHD.

Authors:  Werner Krenger; Georg A Holländer
Journal:  Semin Immunopathol       Date:  2008-10-31       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.